43RD ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE (SFN) SAN DIEGO, CALIFORNIA, USA - NOVEMBER 9-13, 2013

被引：0

作者：

Rabasseda, X. ^{[1
]}

Mason, V. L. ^{[2
]}

机构：

[1] Thomson Reuters, Barcelona 08025, Spain

[2] Thomson Reuters, London, England

来源：

DRUGS OF THE FUTURE | 2013年 / 38卷 / 12期

关键词：

Neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; Huntington's disease; Schizophrenia; Pain; Epilepsy;

D O I：

10.1358/dof.2013.038.12.2086986

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Over 1,000 posters greeted the thousands of attendees who came to San Diego, California for the Society for Neuroscience annual meeting. Parallel nanosymposia also attracted the interest of neuroscientists discussing new research at the meeting, with a significant number of new molecules with the potential to impact the treatment of neuro degenerative diseases, such as Alzheimer's disease, Parkinson's disease or Huntington's disease. A selection of novel molecules reported during the first day of the meeting are described in the following report.

引用

页码：853 / 858

页数：6